Padgett Medical Center Ocala

Weight Loss

Is Personalized Compounded Tirzepatide Right for You?

Updated October 31, 2026 · 7 min read

Personalized compounded tirzepatide may suit adults with obesity, or overweight plus a weight-related problem like high blood pressure. In the weight-loss studies behind the FDA-approved tirzepatide label, that meant a BMI of 30 or more, or 27 or more with one. It is not for anyone with MEN 2 or a personal or family history of medullary thyroid cancer.

At Padgett Medical Center in Ocala, personalized compounded tirzepatide is a weekly injection, dosed for you and medically supervised, from $229 a month at the starting dose. Your provider decides at a visit, after weighing your health history, your medicines and any pregnancy plans.

Who is personalized compounded tirzepatide meant for?

Adults whose weight is affecting their health, as part of a plan to eat fewer calories and move more. The prescribing information for FDA-approved tirzepatide covers adults with obesity, and adults with overweight who have at least one weight-related health problem, to reduce excess weight and keep it off long term.

In the label's main studies, those problems included high blood pressure, cholesterol problems, obstructive sleep apnea and heart or blood vessel disease. Of its four weight-loss studies, three left out people with type 2 diabetes and one enrolled only adults who had it.

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) adds that weight-management medicines are meant for people with weight-related health problems, don't replace healthy eating and physical activity, and should never be taken only to improve how you look.

What BMI do you need for personalized compounded tirzepatide?

In the main weight-loss studies of FDA-approved tirzepatide, adults needed a BMI of 30 or more, or 27 to under 30 with at least one weight-related condition. NIDDK uses the same cut-offs for weight-management medicines in general, naming high blood pressure and type 2 diabetes as examples.

BMI, short for body mass index, measures your weight in relation to your height. NIDDK counts a BMI between 25 and 30 as overweight and 30 or more as obesity. Check yours with the BMI calculator.

A number alone doesn't settle it. NIDDK notes that these medicines aren't for everyone with a high BMI, and that you might be able to lose weight with a lifestyle program instead. Your provider also weighs what BMI can't show, such as your family history and other medicines.

Who should not take personalized compounded tirzepatide?

Anyone with MEN 2, anyone with a personal or family history of medullary thyroid carcinoma (MTC), and anyone who has had a serious allergic reaction to the medicine or its ingredients. Those are the FDA-approved label's contraindications, its do-not-use list.

MTC is a type of thyroid cancer. MEN 2, short for multiple endocrine neoplasia syndrome type 2, is a genetic condition that can cause tumors in more than one hormone-making gland, and MedlinePlus Genetics says its most common sign is MTC. MEN 2 is often passed down from a parent, so ask relatives about thyroid cancer before your visit.

The label reports that in studies in rats, tirzepatide caused thyroid C-cell tumors; whether it causes them in people, including MTC, is unknown. Its Medication Guide asks you to report a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.

The label also does not recommend the medicine for severe gastroparesis, a stomach that empties too slowly, and its safety and effectiveness in children have not been established. During pregnancy, the label says, weight loss offers no benefit and may harm the baby, and NIDDK says never to take a weight-management medicine while pregnant or planning a pregnancy.

What health history should you share before starting?

Anything involving your pancreas, kidneys, stomach or eyes, and any upcoming procedure. Between them, the Medication Guide for FDA-approved tirzepatide and MedlinePlus ask you to mention pancreas problems such as pancreatitis (an inflamed pancreas), kidney disease, severe stomach problems such as trouble digesting food, and diabetic retinopathy, eye damage from diabetes.

Each ties to a label warning. Pancreatitis has been seen in people taking the medicine. Nausea, vomiting or diarrhea can dehydrate you, which may lead to kidney problems. Diabetic eye disease has temporarily worsened when blood sugar improved quickly. Gallbladder problems, such as an inflamed gallbladder, also happened more often with treatment, and the label ties them to weight loss.

Planning surgery, even dental surgery, or a procedure with anesthesia or deep sedation? Tell your provider, and tell whoever does it that you take this medicine. The label reports rare cases of food or liquid getting into the lungs during such procedures in people on GLP-1 medicines, even when they said they had fasted as told.

If you've had a severe allergic reaction to another GLP-1 medicine, such as swelling of the face or throat, mention it. The label urges caution, since it's unknown whether you'd be prone to the same reaction.

Does personalized compounded tirzepatide affect birth control or pregnancy plans?

It may make birth control pills less reliable. The FDA-approved tirzepatide label explains that the medicine slows how fast your stomach empties, which may make pills taken by mouth less effective. That delay is largest after the first dose and fades over time.

If you take the pill, the label recommends switching to a method you don't swallow, or adding a barrier method such as condoms, for 4 weeks after starting and 4 weeks after every dose increase. How personalized compounded tirzepatide doses work explains when increases happen.

Tell your provider if you are trying to get pregnant or are breastfeeding, and call right away if you become pregnant while on the medicine.

Which medicines should your provider know about?

Every one, including over-the-counter medicines, vitamins and herbal supplements. The FDA-approved tirzepatide Medication Guide warns that it may change how some medicines work, and some may change how it works. Keep a written list for your provider and pharmacist.

Diabetes medicines come first: with insulin or a sulfonylurea, a type of diabetes pill, the risk of low blood sugar can rise. In a study of adults with type 2 diabetes described in the FDA-approved label, blood sugar fell below 54 mg/dL in 10.3% of those on the drug who also took a sulfonylurea, versus 2.1% of those on it without one. The label has prescribers consider lowering those doses at the start; only your prescribers should make that change.

Pills that need exact levels come next. Because the medicine slows stomach emptying, it can change how other pills are absorbed, so the label asks prescribers to watch closely when a pill only works safely within a narrow range, such as the blood thinner warfarin.

Last, mention any GLP-1 medicine you already take, for diabetes or weight, even one prescribed elsewhere. The FDA-approved label does not recommend using tirzepatide alongside any GLP-1 medicine or another tirzepatide product. Moving from one to another is your provider's call; see switching to personalized compounded tirzepatide.

What if personalized compounded tirzepatide isn't the right fit?

Your provider talks through other options with you. If MTC or MEN 2 is the reason, personalized compounded semaglutide doesn't get around it: the FDA-approved semaglutide label carries the same thyroid tumor warning and the same rule against use.

Prefer a pill, or ruled out for GLP-1 medicines altogether? At Padgett, phentermine weight loss in Ocala is the non-GLP-1 option: an FDA-approved appetite suppressant pill labeled for short-term use, with its own safety rules and blood pressure checks at the visits. To compare the two injections, see personalized compounded semaglutide and tirzepatide, compared.

How does Padgett decide if it's right for you in Ocala?

At a visit with Sarah Weir, APRN, an advanced practice registered nurse, in person at 200 SW 8th St., Suite A, just south of downtown Ocala, or by telehealth from anywhere in the state while you are physically in Florida. She reviews your health history, medicines and goals, and no prescription is promised in advance.

If it fits, your care is medically supervised: your dose is personalized and adjusted with your provider over time, and the medication is shipped to your door in Florida. Your provider may prescribe your weekly amount as two smaller injections, for example Monday and Thursday, when side effects call for it. Never change your schedule yourself. The FDA-approved label describes one injection a week; splitting a tirzepatide dose twice a week answers the common questions.

Pricing is by dose, from $229 a month at the starting dose, and the personalized compounded tirzepatide price list shows the other doses. The monthly price is your medication. Your provider visit is $100 and is free when you start medication at that visit; the only other charge is a $50 no-show fee.

You book online, and nothing is charged when you book; a card on file holds your visit. No card? You can still book, but your appointment stays unconfirmed until staff reach you by phone. There's no contract, and the no-show fee, charged if you miss the visit or don't cancel or reschedule at least 24 hours ahead, can count toward your next visit.

When you're ready, book a weight-loss visit online, or call the clinic at (352) 369-0104, Monday to Friday, 9:00 AM to 5:00 PM.

Personalized compounded semaglutide and personalized compounded tirzepatide are compounded drugs that have not been approved by the FDA. They have not been reviewed by the FDA for safety, effectiveness, or quality. FDA-approved products containing semaglutide and tirzepatide are available. Individual results vary.

This article is educational and is not medical advice. Talk with a licensed provider about your own health, medications and treatment options.

Pending medical review. This article is educational and is not medical advice. Never start, stop, split or change the timing of a prescription based on something you read online. Your provider decides your dose and your schedule.

Frequently asked questions

Can I take personalized compounded tirzepatide if I have an underactive thyroid?

Possibly; an underactive thyroid is not on the do-not-use list. The FDA-approved tirzepatide label rules out people with MEN 2 or a personal or family history of medullary thyroid carcinoma, one specific thyroid cancer. Tell your provider about any thyroid condition, nodule or thyroid medicine, and about thyroid cancer anywhere in your family.

Does personalized compounded tirzepatide affect a birth control patch, ring or shot?

The FDA-approved tirzepatide label says it should not: its warning covers birth control pills taken by mouth, because the medicine slows stomach emptying. MedlinePlus, the National Library of Medicine's consumer site, lists patches, rings and shots as well. Because the two differ, tell your provider exactly which method you use and follow the plan you're given.

Can I take personalized compounded tirzepatide if I have type 2 diabetes?

It may be an option, with extra care. One weight-loss study in the FDA-approved tirzepatide label enrolled only adults with type 2 diabetes. Low blood sugar is more likely if you also take insulin or a sulfonylurea, and diabetic eye disease needs watching, so share your full diabetes plan and report any change in your vision.

Can I use personalized compounded tirzepatide while breastfeeding?

Weight-loss medicines are not recommended while breastfeeding, says the National Institutes of Health's NIDDK, so tell your provider if you are nursing or plan to. The FDA-approved tirzepatide label describes a small single-dose study in which tirzepatide in breast milk was undetectable or low, but there are no data on effects on a breastfed baby or milk supply.

Is there an age limit for personalized compounded tirzepatide?

The FDA-approved tirzepatide label is for adults and sets no upper age limit; it says safety and effectiveness have not been established in children. Age is not on its do-not-use list, so for older adults your provider weighs your overall health and other medicines. GLP-1 weight loss after 60 covers what older adults should plan for.

Can the free phone consultation tell me if I qualify?

No, only your provider can decide that, at a visit. The free consultation is a free 15-minute phone call with the medical staff; it is not a visit with the provider and nothing is prescribed on it. It's a good time to ask how visits, telehealth and pricing work before you book.

Free consultation, zero pressure

Take the first step toward feeling your best

Run through a few quick questions and reserve your free consultation, in person in Ocala or by telehealth anywhere in Florida. Most visits land on the same or next business day.

  • Your goals reviewed by a real provider
  • A plan made for you, never cookie-cutter
  • Visit us in Ocala or go telehealth statewide
  • A warm, judgment-free team